Loading...
Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.
Despite recent advances in the treatment of colon cancer, tumor resistance is a frequent cause of chemotherapy failure. To better elucidate the molecular mechanisms involved in resistance to irinotecan (and its active metabolite SN38), we established SN38-resistant clones derived from HCT-116 and SW...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Association for Cancer Research
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3304472/ https://ncbi.nlm.nih.gov/pubmed/21159664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-2726 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|